https://scholars.lib.ntu.edu.tw/handle/123456789/161572
標題: | The impact on overall survival (OS) of first-line gefitinib (G) and erlotinib (E) and of clinical factors in advanced non-small cell lung cancer (NSCLC) with activating epidermal growth factor receptor mutations (EGFR mut) based on meta-analysis of 1,231 patients (pts) enrolled in 6 major randomized trials. | 作者: | Lee, Chee Davies, Lucy Claire Wu, Yi-Long Mitsudomi, Tetsuya Inoue, Akira Rosell, Rafael Zhou, Caicun Nakagawa, Kazuhiko Throngprasert, Sumitra Fukuoka, Masahiro Gralla, Richard J. Gebski, Val Mok, Tony Yang, James Chih-Hsin |
公開日期: | 2015 | 卷: | 33 | 期: | 15 | 起(迄)頁: | - | 來源出版物: | J. Clin. Oncol. | URI: | http://ntur.lib.ntu.edu.tw//handle/246246/280131 |
顯示於: | 腫瘤醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。